Corinne Fuller has been named the new co-director of the Bioproducts Institute, a research collaboration between Washington State University and PNNL, as of July 2023.
At the Nonproliferation, Counterproliferation, and Disarmament Science Gordon Research Conference, researchers from PNNL shared research and scientific approaches for countering diverse threats.
PNNL has named Biomedical Scientist Tom Metz, an expert on metabolomics and multi-omics within the Biological Sciences Division, a 2023 Laboratory Fellow.
O’Neil met with members of parliament, the shadow parliament, and the UK’s national security organizations. The entire board, along with 100 invited cybersecurity professionals, attended a special event at the House of Commons.
Team brought experience in nuclear waste forms and regulatory policies to the Federally Funded Research and Development Center’s report, which was reviewed by a National Academies’ committee.
Ann Lesperance has been invited to continue her role on the Domestic Preparedness advisory board, which convenes multidisciplinary subject matter experts to support the Domestic Preparedness Journal's editorial plan.
PNNL chemist Christopher Anderton recently named president-elect of the Imaging Mass Spectrometry Society (IMSS). In this new position, he will help lead the merge of IMSS with a European-based society, currently underway.
Bobbie-Jo Webb-Robertson is a leader with a PhD in decision sciences & engineering systems from Rensselaer Polytechnic Institute and experience in managing complex scientific programs and line organizations. She assumed the role 3/13/23.
PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.